FDA Adverse Event Injury Summary report: N

FLEXTEND

MDR report key: 1953611 · Received January 10, 2011

Report

Report Number
2124215-2010-24070
Event Type
Injury
Date Received
January 10, 2011
Date of Event
December 9, 2010
Report Date
March 28, 2016
Manufacturer
CPI - DEL CARIBE
Product Code
DTB
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT AN INVASIVE PROCEDURE WAS PERFORMED TO SURGICALLY ABANDON THE LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION INDICATES THAT THE REASON THE LEAD WAS ABANDONED WAS DUE TO LOSS OF CAPTURE. THE LEAD WAS NOT VISIBLY DAMAGED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE RIGHT VENTRICULAR (RV) LEAD HAD A CONDUCTOR FRACTURE. PACING IMPEDANCE MEASUREMENTS WERE GREATER THAN 2,500 OHMS AND THERE WAS NO CAPTURE. THE DEVICE WAS REPROGRAMMED TO AAIR MODE. TO DATE, THERE HAVE BEEN NO ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND IMPLANTABLE LEAD DTB CPI - DEL CARIBE 4087

Patients

Seq Age Sex Outcome Treatment
1 82 YR Hospitalization| L| R (B)(4)| (B)(4)